Pioneering Life Extension through Biotech Investment

The Covid-19 pandemic renewed interest in public health and has been the catalyst for increased creativity and innovation within technologies such as AI, automation, genetic engineering, and blockchain. Through investment in Web3 and other emerging technologies, the biotech and longevity industries have seen remarkable decentralization, security, traceability, efficiency, speed, and transparency. Artificial intelligence is unlocking drug discovery. Blockchain is powering more effective clinical trial data collection. Genetic engineering is helping us understand our health and the health of those around us. Blockchain and other emerging technologies should be prioritized in the biotech field as they can play a key role in ensuring the well-being of all humans.